A Pharmacokinetic Study of Single Doses of Sativex in Treatment-induced Mucositis

Clinical trial NCT01975688 · TERMINATED

Trial details

NCT number: NCT01975688
Sponsor: GW Pharmaceuticals Ltd
Status: TERMINATED
Phase: Phase 1
Study type: INTERVENTIONAL

Head and Neck Squamous Cell Carcinoma

Start date: 2014-02-01
Primary completion: 2015-03-01
Enrollment: 10

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.